0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Transesophageal Echocardiography To Assess Embolic Risk in Patients with Atrial Fibrillation

Claudia Stollberger, MD; Pavel Chnupa, MD; Gerhard Kronik, MD; Michael Brainin, MD; Josef Finsterer, MD; Barbara Schneider, PhD; and Jorg Slany, MD
[+] Article and Author Information

for the ELAT Study Group. For author affiliations and current author addresses, see end of text. For participants in the ELAT (Embolism in Left Atrial Thrombi) Study Group, see Appendix 1. Grant Support: By the Fonds zur Forderung der Wissenschaftlichen Forschung, the Medizinisch-wissenschaftlicher Fonds des Burgermeisters, the Osterreichische Landerbank, and Wiener Stadtische Versicherung, Vienna, Austria. Requests for Reprints: Claudia Stollberger, MD, Steingasse 31/18, A-1030 Vienna, Austria. Current Author Addresses: Dr. Stollberger: Steingasse 31/18, A-1030 Vienna, Austria.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;128(8):630-638. doi:10.7326/0003-4819-128-8-199804150-00004
Text Size: A A A

Background: Transesophageal echocardiography visualizes the left atrium and its appendage, thrombi, and spontaneous echocardiographic contrast.

Objective: To assess the association of transesophageal echocardiographic characteristics with stroke or embolism in atrial fibrillation.

Design: Multicenter observational follow-up study.

Setting: Hospitals in Austria and Slovakia.

Patients: 409 outpatients with nonrheumatic atrial fibrillation and without recent stroke.

Intervention: Patients with thrombi received anticoagulation, and patients without thrombi received aspirin.

Measurements: Primary events were stroke or embolism. Secondary events were death not caused by stroke or embolism and need for anticoagulation.

Results: In the left atrium or left atrial appendage, 10 patients (2.5%) had thrombi and 47 (12%) had spontaneous echocardiographic contrast. The appendage had a mean (±SD) length of 44 ± 10 mm, a mean width of 23 ± 6 mm, and a mean area of 5.8 ± 2.5 cm2. Follow-up ranged from 1 to 74 months (mean, 58 months). Fifty patients had stroke or embolism, 53 died of a cause other than stroke or embolism, and 38 required anticoagulation. On univariate analysis, thrombi (risk ratio, 3.9 [95% CI, 1.4 to 10.1]; P = 0.009), length of the left atrial appendage (risk ratio, 1.6 [CI, 1.05 to 2.5]; P = 0.03), and width of the left atrial appendage (risk ratio, 2.4 [CI, 1.2 to 4.8]; P = 0.01) were associated with stroke or embolism. Multivariate analysis identified hypertension (risk ratio, 3.6 [CI, 1.8 to 8.4]; P = 0.001), previous stroke (risk ratio, 3.7 [CI, 1.5 to 7.5]; P = 0.002), and age (risk ratio, 1.1 [CI, 1.0 to 1.1]; P < 0.001) as risk factors for stroke or embolism and provided evidence of an association between thrombi and stroke or embolism (risk ratio, 2.4 [CI, 0.9 to 6.9]; P = 0.09).

Conclusions: In outpatients with atrial fibrillation and without recent stroke, thrombi of the left atrium or left atrial appendage and length and width of the left atrial appendage were associated with stroke or embolism in univariate analysis. In a multivariate analysis, age, hypertension, and previous stroke were risk factors for stroke or embolism, and thrombi of the left atrium or left atrial appendage were possible risk factors. In these patients, history may be more useful than transesophageal echocardiography for the assessment of embolic risk.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)